No Data
Novo Nordisk Options Trading: A Deep Dive Into Market Sentiment
Deep-pocketed investors have adopted a bullish approach towards Novo Nordisk (NYSE:NVO), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled
Express News | Restricting the sales of Saxenda in China? Novo Nordisk responds.
Novo Nordisk Fully Valued Amid Limited Longer-Term Visibility -- Market Talk
1201 GMT - Novo Nordisk trades near all-time highs, with the stock priced for a sustainable GLP-1 franchise beyond the patent expiration of its blockbuster semaglutide drug, UBS analyst Jo Walton writ
Why Micron Is a Better Market Indicator Than S&P 500 Rally, Trump, Biden
Express News | Novo Nordisk responds to "limited supply of weight loss miracle drug in China": Will distribute existing product supply in a responsible manner in global market.
"Muscle gain and fat loss" becomes a new trend in the tens of billions of weight loss market, attracting attention with the cooperation between Kalbe Pharma-B (02105) and Novo Nordisk on muscle gain and fat loss research.
With the mutual efforts with Novo-Nordisk, Laike Pharmaceutical is expected to become a frontrunner in the global weight loss market worth hundreds of billions, and achieve a leap in its own valuation in the future.